
CIK 0001951222
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | $150 15.0K sh | Nov 3, 2026 traded Nov 2, 2026 | |
Enguent Jean-PierreVice President, R&DSS |
Option exercise · 10b5-1 plan |
| M |
| — 20.0K sh |
| Nov 3, 2026 traded Nov 2, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Grant or award · 10b5-1 plan | A | — 50.0K sh | Nov 3, 2026 traded Nov 2, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | — 15.0K sh | Nov 3, 2026 traded Nov 2, 2026 |
| 13 | Enguent Jean-PierreVice President, R&DSS | Open-market sale · 10b5-1 plan | SELL | $48K 35.0K sh | Nov 3, 2026 traded Nov 3, 2026 |
| 7 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | $200 20.0K sh | Nov 3, 2026 traded Nov 2, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | $350 35.0K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | — 35.0K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 16 | Enguent Jean-PierreVice President, R&DSS | Open-market sale · 10b5-1 plan | SELL | $86K 35.0K sh | Oct 7, 2026 traded Oct 6, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Grant or award · 10b5-1 plan | A | — 50.0K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 19 | Pellaton Eric AdrienDirector | Grant or award | A | — 14.1K sh | Oct 6, 2026 traded Sep 25, 2026 |
| 9 | Ward PeterDirector | Grant or award | A | — 4,686 sh | Oct 6, 2026 traded Oct 5, 2026 |
| 9 | Ward PeterDirector | Grant or award | A | — 3,582 sh | Oct 6, 2026 traded Oct 5, 2026 |
| 19 | Fergusson David AlexanderDirector | Grant or award | A | — 14.1K sh | Oct 6, 2026 traded Sep 25, 2026 |
| 19 | Fergusson David AlexanderDirector | Grant or award | A | — 3,424 sh | Oct 6, 2026 traded Sep 25, 2026 |
| 19 | Pellaton Eric AdrienDirector | Grant or award | A | — 10.7K sh | Oct 6, 2026 traded Sep 25, 2026 |
| 13 | Enguent Jean-PierreVice President, R&DSS | Open-market sale · 10b5-1 plan | SELL | $36K 15.0K sh | Sep 3, 2026 traded Sep 3, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | $150 15.0K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | — 15.0K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Ward PeterDirector | Option exercise | M | — 13.6K sh | Jun 18, 2026 traded Jun 16, 2026 |
| 9 | Ward PeterDirector | Option exercise | M | — 353.1K sh | Jun 18, 2026 traded Jun 16, 2026 |
| 27 | Ward PeterDirector | Tax withholding | F | $296K 96.5K sh | Jun 18, 2026 traded Jun 16, 2026 |
| 21 | Ward PeterDirector | Option exercise | M | $3,667 366.7K sh | Jun 18, 2026 traded Jun 16, 2026 |
| 8 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $502 143 sh | Jun 5, 2026 traded Jun 5, 2026 |
| 8 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $20K 5,582 sh | Jun 3, 2026 traded Jun 3, 2026 |
| 8 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $37K 10.0K sh | Jun 3, 2026 traded Jun 2, 2026 |
| 7 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | — 15.0K sh | Jun 3, 2026 traded Jun 1, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Grant or award · 10b5-1 plan | A | — 60.0K sh | Jun 3, 2026 traded Jun 1, 2026 |
| 26 | Enguent Jean-PierreVice President, R&DSS | Open-market sale · 10b5-1 plan | SELL | $53K 15.0K sh | Jun 3, 2026 traded Jun 3, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | $150 15.0K sh | Jun 3, 2026 traded Jun 1, 2026 |
| 13 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $16K 4,689 sh | May 29, 2026 traded May 27, 2026 |
| 20 | Moreira CarlosDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $15K 4,139 sh | May 29, 2026 traded May 27, 2026 |
| 11 | Moreira CarlosDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $35K 10.0K sh | May 29, 2026 traded May 29, 2026 |
| 8 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $35K 10.0K sh | May 29, 2026 traded May 29, 2026 |
| 31 | Buonanno Franck JeanVice-President, Global Sales | Open-market sale · 10b5-1 plan | SELL | $58K 20.0K sh | May 15, 2026 traded May 14, 2026 |
| 7 | Buonanno Franck JeanVice-President, Global Sales | Option exercise · 10b5-1 plan | M | $200 20.0K sh | May 11, 2026 traded May 11, 2026 |
| 0 | Buonanno Franck JeanVice-President, Global Sales | Option exercise · 10b5-1 plan | M | — 20.0K sh | May 11, 2026 traded May 11, 2026 |
| 23 | Enguent Jean-PierreVice President, R&DSS | Open-market sale · 10b5-1 plan | SELL | $47K 15.0K sh | May 7, 2026 traded May 6, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | — 15.0K sh | May 4, 2026 traded May 4, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | $150 15.0K sh | May 4, 2026 traded May 4, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $15K 5,250 sh | Apr 24, 2026 traded Apr 24, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $29K 10.0K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $31K 10.0K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 8 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $28K 10.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 8 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $30K 10.0K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 8 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $27K 10.0K sh | Apr 17, 2026 traded Apr 16, 2026 |
| 8 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $27K 10.0K sh | Apr 17, 2026 traded Apr 17, 2026 |
| 0 | O'Hara John CharlesDirector, Chief Financial Officer | Grant or award · 10b5-1 plan | A | — 130.5K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 4 | O'Hara John CharlesDirector, Chief Financial Officer | Option exercise · 10b5-1 plan | M | $1,305 130.5K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 0 | O'Hara John CharlesDirector, Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 130.5K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 32 | Enguent Jean-PierreVice President, R&DSS | Open-market sale · 10b5-1 plan | SELL | $33K 15.0K sh | Apr 9, 2026 traded Apr 8, 2026 |
| 5 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | $150 15.0K sh | Apr 9, 2026 traded Apr 6, 2026 |
| 13 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $21K 10.0K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 13 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $21K 10.0K sh | Apr 9, 2026 traded Apr 9, 2026 |
| 13 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $22K 10.0K sh | Apr 9, 2026 traded Apr 8, 2026 |
| 5 | Enguent Jean-PierreVice President, R&DSS | Option exercise · 10b5-1 plan | M | — 15.0K sh | Apr 9, 2026 traded Apr 6, 2026 |
| 0 | Feuardent Moreira AndreasChief Innovation Officer | Option exercise · 10b5-1 plan | M | $100 10.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 32 | Feuardent Moreira AndreasChief Innovation Officer | Open-market sale · 10b5-1 plan | SELL | $23K 10.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Feuardent Moreira AndreasChief Innovation Officer | Option exercise · 10b5-1 plan | M | — 10.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 13 | O'Hara John CharlesDirector, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $24K 10.0K sh | Apr 6, 2026 traded Apr 6, 2026 |